Extendicare Stock Total Debt
| EXETFDelisted Stock | USD 5.00 0.00 0.00% |
Extendicare fundamentals help investors to digest information that contributes to Extendicare's financial success or failures. It also enables traders to predict the movement of Extendicare Pink Sheet. The fundamental analysis module provides a way to measure Extendicare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Extendicare pink sheet.
Extendicare |
Extendicare Company Total Debt Analysis
Extendicare's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Extendicare Total Debt | 463.27 M |
Most of Extendicare's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Extendicare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Extendicare has a Total Debt of 463.27 M. This is 83.16% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 91.29% higher than that of the company.
Extendicare Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Extendicare's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Extendicare could also be used in its relative valuation, which is a method of valuing Extendicare by comparing valuation metrics of similar companies.Extendicare is currently under evaluation in total debt category among its peers.
Extendicare Fundamentals
| Return On Equity | 0.0018 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 556.43 M | ||||
| Shares Outstanding | 83.94 M | ||||
| Shares Owned By Insiders | 13.15 % | ||||
| Shares Owned By Institutions | 17.61 % | ||||
| Price To Earning | 500.00 X | ||||
| Price To Book | 4.28 X | ||||
| Price To Sales | 0.32 X | ||||
| Revenue | 1.22 B | ||||
| Gross Profit | 283.88 M | ||||
| EBITDA | 79.64 M | ||||
| Net Income | 11.5 M | ||||
| Cash And Equivalents | 174.61 M | ||||
| Cash Per Share | 2.08 X | ||||
| Total Debt | 463.27 M | ||||
| Debt To Equity | 2.85 % | ||||
| Current Ratio | 1.09 X | ||||
| Book Value Per Share | 1.49 X | ||||
| Cash Flow From Operations | 63.42 M | ||||
| Earnings Per Share | 0.01 X | ||||
| Number Of Employees | 31 | ||||
| Beta | 1.2 | ||||
| Market Capitalization | 419.69 M | ||||
| Total Asset | 900.32 M | ||||
| Z Score | 1.0 | ||||
| Annual Yield | 0.07 % | ||||
| Five Year Return | 6.60 % | ||||
| Net Asset | 900.32 M | ||||
| Last Dividend Paid | 0.48 |
About Extendicare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Extendicare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Extendicare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Extendicare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Extendicare Pink Sheet
If you are still planning to invest in Extendicare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Extendicare's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |